Ergomed, a specialist oncology and rare disease CRO, has acquired MedSource Would you like to learn more? GO TO ERGOMEDCRO.COM STAY ON MEDSOURCE.COM ✕ This site uses cookies to provide user functionality. Read More. Acknowledge MedSource Oncology Neurology Rare Disease Services Resources About Contact Experience. Focus. TRUST. Respect. If these aren’t words you typically associate with a CRO, perhaps it’s time to consider MedSource. At MedSource, we take relationships as seriously as science. Oncology Neurology Rare Disease Biotech Services MedSource provides support for complex clinical trials with expertise in complex therapeutic areas such as oncology, neurology, and rare diseases and complicated study designs from first- in- human dose escalation to adaptive designed registration studies. As a company that supports the most complex clinical trials, we know they aren’t called trials for nothing. At MedSource, we know how to pivot to the demands of even the most challenging trial and how to support the needs of our biotech customers with flexibility and transparency throughout the study life cycle. Connect Follow us on the social media platforms below. About Privacy Policy Contact Ergomed PrimeVigilance Project Management Clinical Monitoring Data Management Biostatistics Scientific Development Oncology Neurology Rare Disease Case Studies News Blog Copyright © 2021 MedSource. All rights reserved. Custom Wordpress Website & Marketing by TheeDesign Oncology Neurology Rare Disease Services Resources About